Jefferies raised its price target on Infinity Pharmaceutical (NASDAQ: INFI) from $21 to $41 while maintaining a Hold rating following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE